Chiral Chromatography Column Market worth $123 million by 2025

Global Growth Boosting Factors:

Increasing R&D investments in the pharmaceutical and biotechnology industry is driving the growth of the market. Moreover, growth opportunities in emerging countries as well as the emergence of green chemistry,is likely to provide opportunities for the chiral chromatography column industry.

Expected Surge in Revenue:

The chiral chromatography column market size is projected to reach USD 123 million by 2025 from an estimated USD 99 million in 2020, at a CAGR of 4.5% during the forecast period.

Global Industry Segmentation:

The pharmaceutical&biotechnology companies end-user segment is expected to grow at the highest CAGR from 2020 to 2025.

Pharmaceutical and biotechnology companies are among the key end-users of chiral chromatography columns.Increasing R&D for therapeutic areas, such as cancer, HIV/AIDS, and immunodeficiency disorders, technological innovations in biotechnology research, increasing focus of pharmaceutical and biotechnology companies on extending their product pipeline, rising number of drug discovery and clinical trial projects, and patent expiry of blockbuster drugs and biomolecules are some of the key factors driving the growth of this segment during the forecast period. Additionally, the availability of government and corporate funding for biotechnology and pharmaceutical research, growth of the pharmaceutical industry, and the presence of stringent regulatory guidelines for drug development and safety are other key factors driving the growth of this segment.

Download PDF Brochure@ 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=225453435

Recent Developments: 

In January 2020, Thermo Fisher entered into an agreement with Astrea Bioseparations to supply EvolveD columns, which include proprietary CaptureSelect and POROS chromatography resins that have been manufactured by Astrea. The columns and resins are used as a part of the molecule purification process to develop biotherapeutics.

In March 2019, the company introduced the new Thermo Scientific TriPlus 500 Gas Chromatography Headspace Autosampler that provides a scalable, compact design that is reliable, efficient, and capable of handling samples at high-throughput for pharmaceutical, food safety, and environmental scientists performing regulatory-compliant volatile organic compound (VOC) analysis.

In January 2018, the company introduced FAME GC columns. Agilent J&W DB-FastFAME GC columns feature a mid-content cyanopropyl phase (USP G48). They are engineered for rapid, selective analysis of saturated and polyunsaturated FAMEs, including challenging cis-trans isomers cis-trans isomers.

The metal based segment is expected to grow at the highest CAGR in the chiral chromatography column industry during the forecast period.

The increasing use of HPLC columns in academic institutes as well as in industries where high pressure is employed is likely to drive the market for stainless steel columns in the coming years. Agilent offers the SEC-5 HPLC columns packed with silica particles and coated with a neutral hydrophilic layer, which decreases sample-column interactions and improves peak capacity and resolution. Other prominent players in this market include Thermo Fisher Scientific, Inc., and Merck KGaA. Therefore, the high demand of metal-based columns in the pharmaceutical industry isexpected to emerge as key revenue pockets for the metal-based columns in the chiral chromatography column market.

Key Questions Addressed by the Report:

The report identifies and addresses the key segments of the chiral chromatography column market, which will help manufacturers and service providers review the growth in demand.

The report helps system providers understand the pulse of the market and provides insights regarding the drivers, restraints, opportunities, and challenges.

The report will help key players understand the strategies of their competitors better and make more pivotal strategic decisions.

The report addresses the market share analysis of key players in the chiral chromatography column market. With the help of this, companies can enhance their revenues in their respective markets.

The report provides insights about emerging geographies for chiral column sales, and hence, the entire market ecosystem can gain a competitive advantage.

The prepacked column is expected to grow at the highest CAGR during the forecast period.

Prepacked/ready-to-use columns are prefilled with the stationary phase and can directly be attached to chromatographic systems. Prepacked columns exhibit minimal variations and are uniform in nature. These columns are used for early method development for optimizing column packing. These columns are widely used in industries due to their ability to run large amounts of samples on adaily basis. Due to this, prepacked columns dominate the chiral chromatography columns market.

Request Sample Pages@ 
https://www.marketsandmarkets.com/requestsampleNew.asp?id=225453435

Chromatography columns are critical factors to the successful separation of valuable molecules. Pharmaceutical and biotechnology companies are extending their offering of standard, custom, and prepacked columns from lab-scale to pilot and process-scale. Prepacked large-scale columns meet the needs of manufacturing with single-use technologies.

Global Key Players:

To enable an in-depth understanding of the competitive landscape, the report includes the profiles of some of the top players in the chiral chromatography column market. The major players in the chiral chromatography column industry are Agilent Technologies (US), Thermo Fisher Scientific(US), Waters Corporation(US), Daicel Corporation (Japan), Bio-Rad Laboratories(US), W.R.Grace & Co. (US), Merk Group(Germany), GL Sciencies(Japan), Perkin Elmer (US), Shimadzu Corporation (Japan), Sartorious Group (Germany), Cytiva(US), ES Industruies (US), and Phenomenex  (US)

These players are adopting various strategies to increase their share in the chiral chromatography column market. Contracts & agreements,new product launches, investments and expansions and mergers have been a widely adopted strategy by the major players in the chiral chromatography column industry.